# IQVIA (United States)

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/iqvia-united-states/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 34 |
| Citations | 223,966 |
| City | Durham |
| Country | US |
| Description | IQVIA (United States) is a research organisation in Durham, US. OpenAlex records 5,815 works and 223,966 citations for it. 1,513 researchers list it as their most recent affiliation. |
| Homepage | https://www.iqvia.com/ |
| OpenAlex ID | https://openalex.org/I4210108991 |
| Region | North Carolina |
| Researchers | 1,513 |
| ROR ID | https://ror.org/01mk44223 |
| Type | company |
| Works | 5,815 |

## University papers

Showing 12 of 32.

- [Five-Year Outcomes of Gastric Bypass in Adolescents as Compared with Adults](https://scholariq.org/papers/five-year-outcomes-of-gastric-bypass-in-adolescents-as-compared-with-adults/)
- [Association of Trauma-Related Disorders and Dissociation with Four Idioms of Distress Among Latino Psychiatric Outpatients](https://scholariq.org/papers/association-of-trauma-related-disorders-and-dissociation-with-four-idioms-of/)
- [Nephrotoxicity and other adverse events among inpatients receiving liposomal amphotericin B or amphotericin B lipid complex](https://scholariq.org/papers/nephrotoxicity-and-other-adverse-events-among-inpatients-receiving-liposomal/)
- [Enzymes of drug metabolism during delirium](https://scholariq.org/papers/enzymes-of-drug-metabolism-during-delirium/)
- [Treatment patterns and patient characteristics among early initiators of PCSK9 inhibitors](https://scholariq.org/papers/treatment-patterns-and-patient-characteristics-among-early-initiators-of-pcsk9/)
- [Lifetime cost of everolimus vs axitinib in patients with advanced renal cell carcinoma who failed prior sunitinib therapy in the US](https://scholariq.org/papers/lifetime-cost-of-everolimus-vs-axitinib-in-patients-with-advanced-renal-cell/)
- [Impact of Motivational Pharmacotherapy on Treatment Retention Among Depressed Latinos](https://scholariq.org/papers/impact-of-motivational-pharmacotherapy-on-treatment-retention-among-depressed/)
- [<p>Treatment Adherence And Persistence Among HIV-1 Patients Newly Starting Treatment</p>](https://scholariq.org/papers/and-lt-p-and-gt-treatment-adherence-and-persistence-among-hiv-1-patients-newly/)
- [Orphan Drug Expenditures In The United States: A Historical And Prospective Analysis, 2007–18](https://scholariq.org/papers/orphan-drug-expenditures-in-the-united-states-a-historical-and-prospective/)
- [Real-World Treatment Patterns, Time to Next Treatment, and Economic Outcomes in Relapsed or Refractory Multiple Myeloma Patients Treated with Pomalidomide or Carfilzomib](https://scholariq.org/papers/real-world-treatment-patterns-time-to-next-treatment-and-economic-outcomes-in/)
- [Improving Medication Adherence and Health Care Outcomes in a Commercial Population through a Community Pharmacy](https://scholariq.org/papers/improving-medication-adherence-and-health-care-outcomes-in-a-commercial/)
- [Medication adherence, hospitalization, and healthcare resource utilization and costs in patients with pulmonary arterial hypertension treated with endothelin receptor antagonists or phosphodiesterase type‐5 inhibitors](https://scholariq.org/papers/medication-adherence-hospitalization-and-healthcare-resource-utilization-and/)

## University researchers

- [Rolin L. Wade](https://scholariq.org/researchers/rolin-l-wade/)
- [Magdaliz Gorritz](https://scholariq.org/researchers/magdaliz-gorritz/)
- [Joseph Imperato](https://scholariq.org/researchers/joseph-imperato/)

## University top topics

Showing 8 of 25.

- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)
- [Statistical Methods in Clinical Trials](https://scholariq.org/topics/statistical-methods-in-clinical-trials/)
- [Pharmaceutical Economics and Policy](https://scholariq.org/topics/pharmaceutical-economics-and-policy/)
- [Economic and Financial Impacts of Cancer](https://scholariq.org/topics/economic-and-financial-impacts-of-cancer/)
- [Medication Adherence and Compliance](https://scholariq.org/topics/medication-adherence-and-compliance/)
- [Biosimilars and Bioanalytical Methods](https://scholariq.org/topics/biosimilars-and-bioanalytical-methods/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.